$6.930
-0.484 (-6.98%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
AVTX Prediction & Forecast by Similar Chart Analysis
Alphio's AVTX stock price prediction model matches the current Avalo Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $6.93 (-0.07%). The 1-week path is $6.93 (+0.04%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Avalo Therapeutics, Inc. Stock?
Avalo Therapeutics Inc is currently not a good buy due to its significant price decline and negative financial performance, despite some positive analyst outlooks. The current price is $6.93, which is down 61.48% over the past year, and the RSI is extremely low at 11.716, indicating oversold conditions. The main risk is the negative earnings per share of -0.83 reported last quarter, which reflects ongoing financial struggles.
AVTX stock price ended at $6.93 on Friday, after losing -6.98%
Avalo Therapeutics, Inc. (AVTX) last closed at $6.93, losing -6.98%. These facts feed the 1-day and 1-week AVTX price prediction above.
Forecast Drivers
Avalo Therapeutics, Inc. (AVTX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches AVTX, ranked by similarity.
Seasonality analysis for AVTX
Historically the probability of a positive October return for AVTX is 73.02%. November offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for AVTX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $3.26 | $4.61 | $5.75 | -33.47% |
| Nov 2026 | $4.11 | $4.66 | $5.49 | -32.71% |
| Dec 2026 | $3.39 | $4.08 | $5.12 | -41.18% |
In 2026, Avalo Therapeutics, Inc. (AVTX) is projected to range from $3.26 to $5.75.
Avalo Therapeutics, Inc. 2026 monthly forecast
In Oct 2026, Avalo Therapeutics, Inc. is projected to average $4.61, with a low of $3.26 and high of $5.75.
In Nov 2026, Avalo Therapeutics, Inc. is projected to average $4.66, with a low of $4.11 and high of $5.49.
In Dec 2026, Avalo Therapeutics, Inc. is projected to average $4.08, with a low of $3.39 and high of $5.12.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.